Neupogen

DRUG11 trials

Conditions

AL AmyloidosisBone Marrow TransplantationBrain and Central Nervous System TumorsChemotherapy-Induced NeutropeniaChronic Lymphocytic LeukemiaColorectal CancerDiffuse, Large B-Cell, LymphomaDrug/Agent Toxicity by Tissue/Organ

Phase 2

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

TerminatedNCT00074165

OHSU Knight Cancer InstituteBrain and Central Nervous System Tumors, Drug/Agent Toxicity by Tissue/Organ, Lymphoma +1

Start: 2003-01-31End: 2010-12-31Updated: 2023-07-06

Tandem Auto-Allo Transplant for Lymphoma

CompletedNCT01181271

Massachusetts General HospitalChronic Lymphocytic Leukemia, Diffuse, Large B-Cell, Lymphoma, Hodgkin's Lymphoma +4

Start: 2010-08-31End: 2016-02-29Updated: 2017-03-09

Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers

WithdrawnNCT02682953

University of Maryland, BaltimoreBone Marrow Transplantation, Hematopoietic Stem Cells, Lymphoma +1

Start: 2015-10-31End: 2017-08-31Updated: 2019-12-11

The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency

CompletedNCT06117982

Trio FertilityPremature Ovarian Failure, Primary Ovarian Insufficiency

Start: 2023-10-13End: 2025-05-01Updated: 2025-05-08

Phase 3

Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF)

CompletedNCT00776165

Shantha Biotechnics LimitedChemotherapy-Induced Neutropenia

Start: 2007-10-31End: 2009-09-30Target: 126Updated: 2010-02-03

Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib

TerminatedNCT02489500

Boston Medical CenterAL Amyloidosis

Start: 2015-06-30End: 2017-04-28Updated: 2018-09-10

Phase 4

Use Art-assist and Neupogen to Treat Chronic Limb Ischemia

WithdrawnNCT02408991

University of ChicagoLower Limb Ischemia

Start: 2014-09-30End: 2015-07-31Updated: 2016-04-08

Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia

CompletedNCT02816112

Ottawa Hospital Research InstituteEarly Stage Breast Cancer

Start: 2016-09-30End: 2020-04-30Updated: 2020-05-27

A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia

CompletedNCT02816164

Ottawa Hospital Research InstituteEarly Stage Breast Cancer

Start: 2016-09-30End: 2019-02-28Updated: 2019-09-06

Unknown Phase

Use of Gcsf in Patients With Recurrent Ivf/Icsi Failure

CompletedNCT03023774

Ain Shams Maternity HospitalFertility Disorders

Start: 2016-06-30End: 2016-12-31Updated: 2017-01-18

Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases

Not yet recruitingNCT06504901

The First Affiliated Hospital with Nanjing Medical UniversityColorectal Cancer

Start: 2024-07-10End: 2027-07-10Target: 30Updated: 2024-07-17

Related Papers

Granulocyte colony-stimulating factor treatment in women with premature ovarian insufficiency: a pilot clinical study of biological activity and menstrual resumption.

2026-01-07

A multicenter study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of taxotere/cyclophosphamide-induced febrile neutropenia in patients with early-stage breast cancer.

Journal of Clinical Oncology2020-05-201 citations

A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer.

2020-04-2026 citations